These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 2887312

  • 1. Biochemical and pharmacological characterization of ganglionic dopamine receptors.
    Sabouni MH, Alkadhi KA, Lokhandwala MF.
    Clin Exp Hypertens A; 1987; 9(5-6):873-87. PubMed ID: 2887312
    [Abstract] [Full Text] [Related]

  • 2. Activation of DA1 receptors by dopamine or fenoldopam increases cyclic AMP levels in the renal artery but not in the superior cervical ganglion of the rat.
    Alkadhi KA, Sabouni MH, Ansari AF, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):547-53. PubMed ID: 2874213
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH, Alkadhi KA, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Jan; 236(1):65-70. PubMed ID: 2867216
    [Abstract] [Full Text] [Related]

  • 4. Effect of dopamine receptor activation on ganglionic transmission and cyclic AMP levels in the stellate ganglia and renal arteries of the dog.
    Sabouni MH, Alkadhi KA, Lokhandwala MF.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):93-8. PubMed ID: 2879905
    [Abstract] [Full Text] [Related]

  • 5. Ganglionic dopamine receptors as mediators of the inhibition of neurogenic vasoconstriction produced by fenoldopam.
    Lokhandwala MF, Sabouni MH.
    J Auton Pharmacol; 1985 Dec; 5(4):301-5. PubMed ID: 2869042
    [Abstract] [Full Text] [Related]

  • 6. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog.
    Shebuski RJ, Fujita T, Smith JM, Kopaciewicz LJ, Blumberg AL, Hieble JP.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207
    [Abstract] [Full Text] [Related]

  • 7. Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.
    Cavero I, Thiry C, Pratz J, Lawson K.
    Clin Exp Hypertens A; 1987 Dec; 9(5-6):931-52. PubMed ID: 2887315
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the hypotensive action of dopamine receptor agonists fenoldopam and quinpirole in anaesthetized rats.
    Sengupta S, Lokhandwala MF.
    J Auton Pharmacol; 1985 Dec; 5(4):289-94. PubMed ID: 2869041
    [Abstract] [Full Text] [Related]

  • 9. Effects of SK&F 85174, a DA-1/DA-2 receptor agonist, on pre- and postganglionic sympathetic neurotransmission to the heart.
    Dlewati A, Watkins HO, Lokhandwala MF.
    Eur J Pharmacol; 1989 May 19; 164(2):197-203. PubMed ID: 2569408
    [Abstract] [Full Text] [Related]

  • 10. Influence of the dopamine receptor agonists fenoldopam and quinpirole in the rat superior mesenteric vascular bed.
    Dupont AG, Lefebvre RA, Vanderniepen P.
    Br J Pharmacol; 1987 Jul 19; 91(3):493-501. PubMed ID: 2886174
    [Abstract] [Full Text] [Related]

  • 11. Hypotensive and bradycardic effects elicited by spinal dopamine receptor stimulation: effects of D1 and D2 receptor agonists and antagonists.
    Pellissier G, Demenge P.
    J Cardiovasc Pharmacol; 1991 Oct 19; 18(4):548-55. PubMed ID: 1724532
    [Abstract] [Full Text] [Related]

  • 12. Involvement of cyclic-AMP in the hypotensive response to fenoldopam but not to quinpirole in the anaesthetized rat.
    Hegde SS, Lokhandwala MF.
    J Auton Pharmacol; 1988 Mar 19; 8(1):63-8. PubMed ID: 2455721
    [Abstract] [Full Text] [Related]

  • 13. Facilitation of ganglionic transmission by sulpiride: evidence for an inhibitory role of dopamine in the canine sympathetic ganglion.
    Horn PT, Kohli JD, Goldberg LI.
    J Pharmacol Exp Ther; 1982 Nov 19; 223(2):462-8. PubMed ID: 6290639
    [Abstract] [Full Text] [Related]

  • 14. Different dopamine receptor subtypes mediate the neurogenic vasodilation produced by fenoldopam and SK & F 85174 in the dog hindlimb.
    Lokhandwala MF, Watkins HO, Dlewati A.
    Eur J Pharmacol; 1987 Nov 17; 143(3):383-90. PubMed ID: 2891555
    [Abstract] [Full Text] [Related]

  • 15. Effects of alpha adrenoceptor and dopamine receptor agonists and antagonists on ganglionic transmission.
    Satoh Y, Kohli JD, Goldberg LI.
    J Pharmacol Exp Ther; 1989 Oct 17; 251(1):253-7. PubMed ID: 2571718
    [Abstract] [Full Text] [Related]

  • 16. The inhibition of ganglionic transmission via presynaptic dopamine DA1 and postsynaptic DA2 receptor activation in the canine cardiac sympathetic ganglia.
    Mukai M, Kushiku K, Yamada H, Yamada K, Dan K, Furukawa T.
    J Pharmacol Exp Ther; 1996 Nov 17; 279(2):822-9. PubMed ID: 8930189
    [Abstract] [Full Text] [Related]

  • 17. Effects of the dopamine receptor agonists, fenoldopam and quinpirole, in the rat stomach.
    Lefebvre RA, Guenaneche F, De Beurme FA.
    Eur J Pharmacol; 1990 Aug 21; 185(1):69-79. PubMed ID: 1977599
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors.
    Lokhandwala MF, Watkins HO, Sabouni MH, Alkadhi KA.
    J Pharmacol Exp Ther; 1985 Aug 21; 234(2):337-44. PubMed ID: 2862275
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
    Sesack SR, Bunney BS.
    J Pharmacol Exp Ther; 1989 Mar 21; 248(3):1323-33. PubMed ID: 2564893
    [Abstract] [Full Text] [Related]

  • 20. Age-related changes of dopamine sensitive cyclic AMP generation in the rat frontal cortex.
    Amenta F, Cavallotti C, Collier WL, De Michele M, Ricci A.
    Mech Ageing Dev; 1990 May 15; 54(1):63-73. PubMed ID: 1973206
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.